Astellas Pharma Inc. Wins Japan Approval for New Transplant Drug

July 17, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

TOKYO, July 17 (Reuters) - Astellas Pharma Inc said on Thursday it had won approval to sell a new version of its key transplant drug in Japan, the second major region where it has gained approval although it is facing delays in the United States.

Twitter
LinkedIn
Facebook
Email
Print

FDA Approvals Asia

Astellas Pharma US, Inc.